[{"_id":"551f89c231cae9239deb20f8","会社名":"アース製薬(株)【4985】","証券コード":"4985","決算期":"2014年12月期","会計方式":"日本方式","決算発表日":"2015年2月10日","決算月数":"12か月","売上高":"145,858百万円","営業利益":"4,843百万円","経常利益":"6,020百万円","当期利益":"1,705百万円","EPS（一株当たり利益）":"84.47円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,192.88円","総資産":"101,598百万円","自己資本":"44,287百万円","資本金":"3,377百万円","有利子負債":"11,452百万円","自己資本比率":"43.6%","ROA（総資産利益率）":"1.82%","ROE（自己資本利益率）":"3.89%","総資産経常利益率":"6.42%","__v":0,"日付":"2015-04-04T06:50:42.388Z"},{"_id":"551f89c231cae9239deb20f9","会社名":"アース製薬(株)【4985】","証券コード":"4985","決算期":"2013年12月期","会計方式":"日本方式","決算発表日":"2014年2月12日","決算月数":"12か月","売上高":"135,737百万円","営業利益":"5,446百万円","経常利益":"6,469百万円","当期利益":"2,986百万円","EPS（一株当たり利益）":"147.86円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,151.52円","総資産":"85,796百万円","自己資本":"43,452百万円","資本金":"3,377百万円","有利子負債":"5,564百万円","自己資本比率":"50.6%","ROA（総資産利益率）":"3.50%","ROE（自己資本利益率）":"7.04%","総資産経常利益率":"7.57%","__v":0,"日付":"2015-04-04T06:50:42.388Z"},{"_id":"551f89c231cae9239deb20fa","会社名":"アース製薬(株)【4985】","証券コード":"4985","決算期":"2012年12月期","会計方式":"日本方式","決算発表日":"2013年2月13日","決算月数":"12か月","売上高":"125,499百万円","営業利益":"4,125百万円","経常利益":"4,689百万円","当期利益":"1,721百万円","EPS（一株当たり利益）":"85.22円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,048.28円","総資産":"85,064百万円","自己資本":"41,368百万円","資本金":"3,377百万円","有利子負債":"7,438百万円","自己資本比率":"48.6%","ROA（総資産利益率）":"2.19%","ROE（自己資本利益率）":"4.17%","総資産経常利益率":"5.96%","__v":0,"日付":"2015-04-04T06:50:42.388Z"}]